Dr John Chan speaks to ecancer in an online interview for the virtual ASCO 2021 meeting about a review of the incidence and trends of human papillomavirus- (HPV-) related cancers.
Dr Chan explains the background of the study, which looked at the association of HPV and cancer at a population level - particularly concerning cancers that are screenable, unscreenable and that are potentially preventable through vaccination. They wanted to see if there has been a decrease in the number of new cancers that are associated with HPV since the introduction of the vaccine in 2006.
He reports that while they found a decrease in cases of cervical cancer, they also found increases in other HPV related cancers that are not routinely screened for in the United States.
Dr Chan says that these findings suggest that prevention and early detection are clearly the best approaches to decreasing cases of all of these cancers. This requires increasing adherence to screening and wider adoption of the HPV vaccine, particularly in high-risk groups. He notes that this is particularly important for the HPV associated cancers that have not seen a decrease since the introduction of the vaccine, warranting further research and the development of better screening methodologies for these cancers.
Read more on the study here.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.